Searched for
VIRUS PHASE 3
COVID: New antibody treatment could offer up to 18 months' protection against severe diseaseThe treatment contains antibodies, which are usually produced naturally in response to a COVID infection or vaccination. They work by recog...
Sanofi, GSK receive nod for Phase 3 trial of COVID-19 vaccine candidate in IndiaThe design of the Phase 3 study, conducted across a broad diversity of geographies, also allows evaluation of the efficacy of the candidate...
Covaxin neutralises both Alpha, Delta variants of Covid effectively, research by top US health institute findsThe vaccine has so far been given to around 25 million recipients in India and elsewhere. Interim results from Covaxin's Phase 3 trial have...
Chinese Covid vaccine found safe, effective in children, adolescents: Lancet studyThe phase 1/2 trial on 550 young people found that over 96 per cent of children and adolescents who received two doses of the vaccine Coron...
Covaxin phase 3 full trial data to be made public in July: Bharat BiotechThe indigenous whole virion inactivated SARS-Cov-2 virus vaccine company has also said that Covaxin will even undergo the phase 4 trials to...
New COVID vaccine shows 'strong immune response' in early UK trialsUK Health Secretary Matt Hancock said that the promising Phase I and II results mean that the Valneva vaccine, being developed at Livingsto...
Air India to bring first vaccine shipment to Delhi todayIndia, which saw Corona virus infections peak around Diwali, started registering stabilisation in new infections starting November-end. The...
Covaxin can work against mutated coronavirus: Bharat BiotechHe also said the company has approached regulatory authorities seeking approval for an emergency license to use the vaccine, developed in c...
Vaccines that can help India in its fight against Covid-19Experts have said that vaccines like Pfizer that requires super-cold storage may not be ideal for India and will pose a logistical hurdle.
Bharat Biotech to launch Covaxin in Q2 2021The company's vaccine candidate -Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National...
Pan-India COVID-19 genome studies suggest virus genetically stable, no major mutation: PMOThere had been concerns in some quarters that any major mutation detected in the novel coronavirus could hinder the development of an effec...
How are new vaccines developed? Here is the complete processWhat do different phases of a trial test?Phase 1 and 2 test safety and immune response. Safety is one of the most important factors in a va...
US-based firm leads COVID-19 vaccine race, clinical trials show promising early results: ExpertsCautioning that a vaccine is still months, maybe even a year away, experts said the US-based biotechnology firm's results have propelled it...
US drugmaker reports promising early results from COVID-19 vaccine testThe Cambridge, Massachusetts-based company said the vaccine candidate, mRNA-1273, appeared to produce an immune response in eight people wh...
Glenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patientsThe Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipi...
No community transmission of COVID-19, behavioural changes may be new 'healthy' normal: Harsh VardhanHe said the doubling rate of cases in the country has been showing regular improvement and stands at over 12 days now as against three days...
- Swine Flu: A step closer to a pandemic
The World Health Organization (WHO) may declare the outbreak of H1N1 influenza a pandemic even as many cases of swine flu show symptoms no ...